Host Ajay Nair interviews Bruno Occhipinti, CEO of Qritive. Qritive develops AI-powered solutions that enable histopathologic diagnosis of cancer at scale. Their clinical-decision support system for pathologists unlocks efficiency and quality gain in diagnosis, which results in better patient outcomes. It includes AI Modules, an Image Management System platform (Pantheon), and a network of pathologists on-demand for services.